In Re "Agent Orange" Product Liability Litigation

689 F. Supp. 1250, 1988 U.S. Dist. LEXIS 6833, 1988 WL 70295
CourtDistrict Court, E.D. New York
DecidedJuly 5, 1988
DocketMDL 381 (JBW)
StatusPublished
Cited by29 cases

This text of 689 F. Supp. 1250 (In Re "Agent Orange" Product Liability Litigation) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re "Agent Orange" Product Liability Litigation, 689 F. Supp. 1250, 1988 U.S. Dist. LEXIS 6833, 1988 WL 70295 (E.D.N.Y. 1988).

Opinion

*1251 MEMORANDUM AND ORDER ON DISTRIBUTION ON REMAND

WEINSTEIN, District Judge:

TABLE OF CONTENTS

I.PROCEDURAL HISTORY

A. Post-Settlement

B. Appeals

C. Post-Appeal Hearings and Advisory Boards

II.SUMMARY OF ALLOCATION OF FUNDS

A. Original and Revised Payment Program

B. Australian & New Zealand Class Members

C. Class Assistance Program

D. Attorneys’ Fees and Expenses

E. Division of Funds

III. PAYMENT PROGRAM
A. Inclusion of Opt-Out Claimants and Late Claimants
B. Additions and Modifications
1. Exposure Criteria
2. Length
3. Claims Administrator
4. Special Master for Appeals
5. Other Implementation Actions
IV. CLASS ASSISTANCE PROGRAM
A. Original Foundation Concept
B. Post-Appeal Modifications

1. Veterans Advisory Board, Advisor, Executive Director and Staff

2. Alternatives Under Consideration

a. Information and Referral Network

b. Family- and Child-Related Needs

c. Homeless and Disadvantaged Veterans

d. Genetic Counseling

e. Assistance with Rights and Benefits

f. Reserve

g. Tentative Conclusions

3. Data Required
4. Avoiding Duplicative Programs

V.MONEY MANAGEMENT AND ACCOUNTING

A. Present Method

*1252 B. Challenges Confronting Financial Management During Distribution

C. Selection of Contractors to Provide Financial Services
D. Investment and Depositary Arrangements
E. Accounting Services
F. Further Details of Distribution Planning
VI. APPENDICES
A. Sample Letter to Claimants
B. Sample “Application for Payments” Kit

On June 30, 1988, the Supreme Court denied the last two of the seven petitions for certiorari filed in the multidistrict litigation “Agent Orange” case. The only phase of the case now unresolved, and the subject of this memorandum, is the final distribution of the settlement fund.

After three and a half years of appeals, the distribution of the settlement fund is at hand. The court regrets any inconvenience or harm suffered by members of the class as a result of the delays caused by the legal process. Detailed consideration of the issues raised by the lawyers for plaintiffs on appeal was necessary to ensure fairness to members of the class and to their attorneys, and to guarantee compliance with the law in unique and highly complex circumstances.

Issuance of mandates to this court addressing all appeals made in the “Agent Orange” case had been stayed by the Court of Appeals for the Second Circuit, pending the Supreme Court’s determinations on the seven petitions for certiorari. See Court of Appeals’ Orders of July 17, 1987 and August?, 1987; Fed.R.App.P. 41(b). The stay of the mandates was lifted on June 30, 1988 upon denial of the last petitions for certiorari. The case has now been returned to this court for determinations required on remand by the decisions of the Court of Appeals and for implementation of the plan for distribution of the settlement fund.

This order makes necessary modifications to this multidistrict court’s earlier order, In re “Agent Orange” Product Liability Litigation, 611 F.Supp. 1396 (E.D.N.Y.1985), on distribution of the Agent Orange settlement fund. These modifications are required in light of the rulings of the court of appeals and subsequent developments. In particular, the affirmance of the grant of summary judgment against plaintiffs who opted out of the class, and the disapproval of the proposed form of the Class Assistance Foundation, require reconsideration of aspects of the distribution plan. See In re “Agent Orange” Product Liability Litigation, 611 F.Supp. 1223 (E.D.N.Y.1985), aff'd, 818 F.2d 187 (2d Cir.1987), ce rt. denied sub nom. Lombardi v. Dow, - U.S. -, 108 S.Ct. 2898, 101 L.Ed.2d 932 (1988) (opt-outs); In re “Agent Orange” Product Liability Litigation, 611 F.Supp. 1396 (E.D.N.Y.1985), aff'd in part, rev’d in part, 818 F.2d 179, 184-86 (2d Cir.1987) (addressing, inter alia, Class Assistance Foundation).

The court now (1) orders that the opt-out claimants and the claimants who filed late be included within the class which may receive benefits of the Agent Orange Settlement Fund, (2) makes modifications to the Payment Program, (3) appoints a claims administrator for the Payment Program, (4) appoints a Special Master for Appeals from denials of Payment Program benefits, (5) establishes the basis for a set of Class Assistance Programs in place of the Class Assistance Foundation, (6) formally appoints Veterans Advisory Boards for the Payment Program and the Class Assistance Program, (7) takes steps for the prompt funding of projects designed to assist the class, (8) establishes a reserve fund, (9) appoints investment managers and a depositary to hold funds subject to the court’s control, (10) appoints an accounting consultant, and (11) reallocates the settlement fund in light of the decisions of the court of appeals and in order to distribute the interest earned during the appeals.

I. PROCEDURAL HISTORY
A. Post-Settlement

Early on the morning of May 7,1984, the class of veterans exposed to Agent Orange reached a $180 million settlement with the several defendant chemical companies. No payments could be made from the settle *1253 ment fund to class members or to plaintiffs’ attorneys because of the pendency of the appeals.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Grottano v. City Of New York
S.D. New York, 2021
ARcare Inc v. Alere Inc
E.D. Arkansas, 2020
In re the Bear Stearns Companies
297 F.R.D. 90 (S.D. New York, 2013)
Schwab v. Philip Morris USA, Inc.
449 F. Supp. 2d 992 (E.D. New York, 2006)
Pink Triangle Coalition v. Union Bank of Switzerland
424 F.3d 158 (Second Circuit, 2005)
In Re Agent Orange Product Liability Litigation
373 F. Supp. 2d 7 (E.D. New York, 2005)
Dahingo v. Royal Caribbean Cruises, Ltd.
312 F. Supp. 2d 440 (S.D. New York, 2004)
Isaacson v. Dow Chemical Co.
304 F. Supp. 2d 404 (E.D. New York, 2004)
In Re" Agent Orange" Product Liability Lit.
304 F. Supp. 2d 404 (E.D. New York, 2004)
In re Simon II Litigation
211 F.R.D. 86 (E.D. New York, 2002)
In Re Cendant Corporation Prides Litigation
233 F.3d 188 (Third Circuit, 2000)
Welch & Forbes, Inc. v. Cendant Corp.
233 F.3d 188 (Third Circuit, 2000)
In re Cendant Corp. Prides Litigation
189 F.R.D. 321 (D. New Jersey, 1999)
Winsett v. West
11 Vet. App. 420 (Veterans Claims, 1998)
Brock v. Brown
10 Vet. App. 155 (Veterans Claims, 1997)
Georgine v. Amchem Products, Inc.
160 F.R.D. 478 (E.D. Pennsylvania, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
689 F. Supp. 1250, 1988 U.S. Dist. LEXIS 6833, 1988 WL 70295, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-agent-orange-product-liability-litigation-nyed-1988.